Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: Results from a randomized double blind placebo controlled pilot study

BACKGROUND: Deficits in olfactory identification have been widely reported in patients with schizophrenia (SZ) and are associated with negative symptomatology. Adjunctive oxytocin delivered intranasally has been shown to improve some aspects of social cognition as well as positive and negative sympt...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Lee, Mary R., Wehring, Heidi J., McMahon, Robert P., Linthicum, Jared, Cascella, Nicola, Liu, Fang, Bellack, Alan, Buchanan, Robert W., Strauss, Gregory P., Contoreggi, Carlo, Kelly, Deanna L.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4125132/
https://ncbi.nlm.nih.gov/pubmed/23415472
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.schres.2013.01.001
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky